CLINICAL_TRIALS trial_result · 2011-01-25

Clinical Trial Update: Safety and Efficacy Study of Adjunctive Antiplatelet Therapy Prior to Primary PCI in Patients With STEMI [Phase 2]

Phase 2 trial of adjunctive antiplatelet therapy before primary PCI in STEMI patients was terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Portola Pharmaceuticals | Conditions: Myocardial Infarction | Phase 2 | Status: TERMINATED | Results posted: 2011-01-25